This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
+Plus, news about Autolus, MacroGenics and BlissBio: Akeso bispecific looks ...
AstraZeneca is again boosting its manufacturing footprint in China, this time sp...
AstraZeneca is further investing in China, opening an R&D center in Beijing and ...
A Roivant Sciences spinout says it has made the first AI model, to its knowledge...
Johnson & Johnson is planning to invest $55 billion to build up its US footprint...
→ Brian Stephenson has stepped down after more than five years as CFO of BridgeB...
A Roivant Sciences spinout says it has made the first AI model, to its knowledge...
Alnylam’s drug Amvuttra appears to have been approved for a rare heart disease, ...
A meeting of CDC vaccine advisors that’s been in limbo for almost a month is sla...
NEW YORK — Akero Therapeutics may not have adequate data for accelerated approva...
New research published by FDA authors found that 67% of non-oncologic rare disea...
Novo Nordisk is reorganizing its research and early development unit in an effor...
A close ally of HHS Secretary Robert F. Kennedy Jr. is joining the administratio...
SV Health Investors has added $250 million to its hunt for new therapeutics for ...
It feels like people have gotten a lot more comfortable with using AI day to day...